4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-011132
Director sold 30,566 shares at an average $50.29 ($1,537,138)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2018-04-30 | Sale | −26,860 | $50.29 | $1,350,789 | 1,297,334 | I |
| Bolzon Bradley J PhD Director | 2018-04-30 | Sale | −788 | $50.29 | $39,629 | 38,064 | I |
| Bolzon Bradley J PhD Director | 2018-04-30 | Sale | −874 | $50.26 | $43,927 | 42,193 | I |
| Bolzon Bradley J PhD Director | 2018-04-30 | Sale | −2,044 | $50.29 | $102,793 | 98,736 | I |
| Open-market sales · 30,566 sh · avg $50.29 · $1,537,138 | |||||||
Loading xslF345X03/doc4.xml…